Craig Mello

Type: Person
Name: Craig Mello
First reported Jul 15 2014 - Updated Jul 15 2014 - 1 reports

Making the case for investment in early stage biotech companies

[embedded content]Geert Cauwenbergh, President and Chief Executive Officer of RXi Pharmaceuticals, presented at the Stem Cells & Regenerative Medicine Congress in 2013.You can now download his presentation slides from the event, where he addressed making ... [Published Terrapinn - Jul 15 2014]
First reported Jul 07 2014 - Updated Jul 07 2014 - 1 reports

God in Big History (VIDEOS): Factual Faith, Sacred Realism

Big History is humanity's first and only creation story derived from global collective learning. While secular, it nevertheless reveals a way of thinking and speaking about God that is undeniably and inescapably real.A Big History approach to reality ... [Published Huffington Post - Jul 07 2014]
First reported Jul 07 2014 - Updated Jul 07 2014 - 2 reports

RXi Pharmaceuticals Appoints Peter Campochiaro M.D. to its Scientific Advisory Board

MARLBOROUGH, Mass.Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGOWith more than 300 articles published in peer-reviewed medical journals, Dr. Campochiaro is a clinician-scientist who does both laboratory and clinical research. His major ... [Published ADVFN UK - Jul 07 2014]
First reported Jul 02 2014 - Updated Jul 02 2014 - 1 reports

RXi Pharmaceuticals Expands Operations in Massachusetts

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced the official opening ... [Published Citybizlist - Jul 02 2014]
First reported Jun 27 2014 - Updated Jun 28 2014 - 1 reports

Jennifer Doudna, Emmanuelle Charpentier win award for biomedical research

Johnson & Johnson has named Dr. Jennifer Doudna of the University of California at Berkeley and the Howard Hughes Medical Institute , and Dr. Emmanuelle Charpentier, of the Hannover Medical School and Helmholtz Center for Infection Research (HZI), Germany ... [Published Center Watch - Jun 27 2014]
First reported Jun 26 2014 - Updated Jun 27 2014 - 1 reports

A CRISPR Way To Fix Faulty Genes

hide caption The CRISPR enzyme (green and red) binds to a stretch of double-stranded DNA (purple and red), preparing to snip out the faulty part.Illustration courtesy of Jennifer Doudna/UC BerkeleyScientists from many areas of biology are flocking to ... [Published NPR - Jun 26 2014]
First reported Jun 25 2014 - Updated Jun 25 2014 - 1 reports

RXi Pharmaceuticals Set to Join Russell Microcap Index

/PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced the ... [Published Scottrade - Jun 25 2014]
First reported Jun 24 2014 - Updated Jun 24 2014 - 1 reports

Jennifer Doudna, Ph.D., and Emmanuelle Charpentier, Ph.D., Win 2014 Dr. Paul Janssen Award for Biomedical Research

"Their discovery of this new DNA editing strategy is considered one of the most significant breakthroughs in molecular biology in the past decade," said Paul StoffelsThe Dr. Paul Janssen"The transformational research by Drs. Doudna and Charpentier has ... [Published Industrial Info Financials - Jun 24 2014]
First reported May 06 2014 - Updated May 06 2014 - 1 reports

CRISPR In the Courts

Here's an article from the Independent on the legal battles that are underway about CRISPR technology. On one level, it can be a somewhat ugly story, but it also shows how much of a discovery the technique has been, that people are willing to ... [Published In the Pipeline - May 06 2014]
First reported Apr 24 2014 - Updated Apr 24 2014 - 1 reports

CRISPR Therapeutics grabs $25 mln from Versant Ventures

CRISPR Therapeutics has received $25 million in Series A funding from Versant Ventures. Based in Basel, Switzerland, CRISPR Therapeutics is a biopharmaceutical firm focused on gene-editing technology CRISPR-Cas9. PRESS RELEASE BASEL, Switzerland–(BUSINESS ... [Published PE Hub Blog - Apr 24 2014]
First reported Apr 21 2014 - Updated Apr 22 2014 - 1 reports

Revealed: Scientists ‘edit’ DNA to correct adult genes and cure diseases

A genetic disease has been cured in living, adult animals for the first time using a revolutionary genome-editing technique that can make the smallest changes to the vast database of the DNA molecule with pinpoint accuracy. Scientists have used the genome-editing ... [Published The Independent - Apr 21 2014]

Quotes

"it's really powerful, it's a really exciting development" says Craig Mello of the University of Massachusetts Medical School...

More Content

All (13) | News (11) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Making the case for investment in early stage b... [Published Terrapinn - Jul 15 2014]
God in Big History (VIDEOS): Factual Faith, Sac... [Published Huffington Post - Jul 07 2014]
RXi Pharmaceuticals Appoints Peter Campochiaro ... [Published ADVFN UK - Jul 07 2014]
RXi Pharmaceuticals Appoints Peter Campochiaro ... [Published Scottrade - Jul 07 2014]
RXi Pharmaceuticals Expands Operations in Massa... [Published Citybizlist - Jul 02 2014]
Jennifer Doudna, Emmanuelle Charpentier win awa... [Published Center Watch - Jun 27 2014]
A CRISPR Way To Fix Faulty Genes [Published NPR - Jun 26 2014]
RXi Pharmaceuticals Set to Join Russell Microca... [Published Scottrade - Jun 25 2014]
Jennifer Doudna, Ph.D., and Emmanuelle Charpent... [Published Industrial Info Financials - Jun 24 2014]
CRISPR In the Courts [Published In the Pipeline - May 06 2014]
CRISPR Therapeutics grabs $25 mln from Versant ... [Published PE Hub Blog - Apr 24 2014]
Revealed: Scientists ‘edit’ DNA to correct adul... [Published The Independent - Apr 21 2014]
The Next Gene Engineering Revolution: Curing Ge... [Published REASON Online - Nov 07 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
CRISPR In the Courts [Published In the Pipeline - May 06 2014]
Here's an article from the Independent on the legal battles that are underway about CRISPR technology. On one level, it can be a somewhat ugly story, but it also shows how much of a discovery the technique has been, that people are willing to ...
CRISPR Therapeutics grabs $25 mln from Versant ... [Published PE Hub Blog - Apr 24 2014]
CRISPR Therapeutics has received $25 million in Series A funding from Versant Ventures. Based in Basel, Switzerland, CRISPR Therapeutics is a biopharmaceutical firm focused on gene-editing technology CRISPR-Cas9. PRESS RELEASE BASEL, Switzerland–(BUSINESS ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.